Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,573,345
in 6 filings, $32.6M under 10b5-1 plans

Net −$32,573,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Coyne Terrance P. EVP & CFO Sale 10b5-1 −14,751 $68.30 $1.0M 0
2026-11-17 Coyne Terrance P. EVP & CFO Sale 10b5-1 −9,835 $68.30 $672K 0
2026-11-17 Hite Christopher EVP & Chairman, Partnering Sale 10b5-1 −100,000 $68.15 $6.8M 177,523
2026-11-16 Urist Marshall EVP, Research & Investments Sale 10b5-1 −23,592 $69.47 $1.6M 126,408
2026-11-16 Urist Marshall EVP, Research & Investments Sale 10b5-1 −1,408 $69.99 $99K 125,000
2026-11-16 Coyne Terrance P. EVP & CFO Sale 10b5-1 −135,249 $68.87 $9.3M 14,751
2026-11-16 Coyne Terrance P. EVP & CFO Sale 10b5-1 −90,165 $68.87 $6.2M 9,835
2026-11-16 Coyne Terrance P. EVP & CFO Sale 10b5-1 −7,122 $68.87 $490K 0
2026-11-06 Urist Marshall EVP, Research & Investments Conversion +150,000 150,000
2026-11-06 Urist Marshall EVP, Research & Investments Conversion · LP interests in RPI US Partners 2019, LP −15,000 229,412
2026-11-06 Coyne Terrance P. EVP & CFO Conversion +150,000 150,000
2026-11-06 Coyne Terrance P. EVP & CFO Conversion +100,000 100,000
2026-11-06 Coyne Terrance P. EVP & CFO Conversion · LP interests in RPI US Partners 2019, LP −15,000 102,526
2026-11-06 Coyne Terrance P. EVP & CFO Conversion · LP interests in RPI US Partners 2019, LP −10,000 473,942
2026-11-04 Urist Marshall EVP, Research & Investments Grant or award +5,341 5,341
2026-11-04 Coyne Terrance P. EVP & CFO Grant or award +7,122 7,122
2026-11-04 Hite Christopher EVP & Chairman, Partnering Grant or award +7,122 277,523
2026-11-04 Legorreta Pablo G. CEO, Chairman of the Board Grant or award +42,209 1,350,029
2026-10-05 Urist Marshall EVP, Research & Investments Sale 10b5-1 −4,126 $57.10 $236K 0
2026-09-30 Bassler Bonnie L Director Grant or award +642 $58.41 $37K 79,823

Page 1 of 16 · 315 trades